Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000070858-25-000131·BANK OF AMERICA CORP /DE/
Schedule 13G ownership disclosure
Ventyx Biosciences Inc
Common Stock · CUSIP: 92332V107
Event date: 2024-12-31
- Filing-level shares
- 4,616,536.00
- Percent of class
- 6.5%
- BANK OF AMERICA CORP /DE/
Shares: 4,616,536.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-25-000131
- Form type
- SCHEDULE 13G
- Filer
- BANK OF AMERICA CORP /DE/
- CIK
- CIK 70858
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership